nodes	percent_of_prediction	percent_of_DWPC	metapath
Bisoprolol—CYP2D6—epilepsy syndrome	0.265	1	CbGaD
Bisoprolol—CYP3A4—Oxcarbazepine—epilepsy syndrome	0.0305	0.0819	CbGbCtD
Bisoprolol—CYP3A4—Felbamate—epilepsy syndrome	0.0283	0.0761	CbGbCtD
Bisoprolol—CYP3A4—Trimethadione—epilepsy syndrome	0.0283	0.0761	CbGbCtD
Bisoprolol—CYP3A4—Fosphenytoin—epilepsy syndrome	0.0266	0.0716	CbGbCtD
Bisoprolol—CYP2D6—Propofol—epilepsy syndrome	0.0252	0.0677	CbGbCtD
Bisoprolol—CYP3A4—Clonazepam—epilepsy syndrome	0.0241	0.0647	CbGbCtD
Bisoprolol—CYP3A4—Clobazam—epilepsy syndrome	0.0231	0.0621	CbGbCtD
Bisoprolol—CYP3A4—Rufinamide—epilepsy syndrome	0.0196	0.0528	CbGbCtD
Bisoprolol—CYP3A4—Carbamazepine—epilepsy syndrome	0.0191	0.0514	CbGbCtD
Bisoprolol—CYP3A4—Primidone—epilepsy syndrome	0.0179	0.048	CbGbCtD
Bisoprolol—CYP3A4—Phenytoin—epilepsy syndrome	0.0172	0.0461	CbGbCtD
Bisoprolol—CYP3A4—Propofol—epilepsy syndrome	0.016	0.043	CbGbCtD
Bisoprolol—CYP3A4—Acetazolamide—epilepsy syndrome	0.0153	0.0411	CbGbCtD
Bisoprolol—CYP3A4—Phenobarbital—epilepsy syndrome	0.0153	0.0411	CbGbCtD
Bisoprolol—CYP3A4—Midazolam—epilepsy syndrome	0.0151	0.0405	CbGbCtD
Bisoprolol—CYP3A4—Diazepam—epilepsy syndrome	0.0145	0.039	CbGbCtD
Bisoprolol—CYP3A4—Zonisamide—epilepsy syndrome	0.0142	0.038	CbGbCtD
Bisoprolol—CYP3A4—Valproic Acid—epilepsy syndrome	0.0114	0.0307	CbGbCtD
Bisoprolol—CYP3A4—Topiramate—epilepsy syndrome	0.0103	0.0277	CbGbCtD
Bisoprolol—Chlorphenesin—BCHE—epilepsy syndrome	0.000489	0.151	CrCbGaD
Bisoprolol—Metoprolol—CYP2C19—epilepsy syndrome	0.000282	0.0873	CrCbGaD
Bisoprolol—Betaxolol—CYP2D6—epilepsy syndrome	0.000271	0.0839	CrCbGaD
Bisoprolol—Acebutolol—CYP2D6—epilepsy syndrome	0.000248	0.0767	CrCbGaD
Bisoprolol—Oxprenolol—CYP2D6—epilepsy syndrome	0.000246	0.0761	CrCbGaD
Bisoprolol—Chlorphenesin—PTGS2—epilepsy syndrome	0.000226	0.0698	CrCbGaD
Bisoprolol—Alprenolol—CYP2D6—epilepsy syndrome	0.000225	0.0696	CrCbGaD
Bisoprolol—Metoprolol—CYP2D6—epilepsy syndrome	0.000209	0.0647	CrCbGaD
Bisoprolol—Pindolol—CYP2D6—epilepsy syndrome	0.000194	0.0599	CrCbGaD
Bisoprolol—Atenolol—ABCB1—epilepsy syndrome	0.000192	0.0593	CrCbGaD
Bisoprolol—Acebutolol—ABCB1—epilepsy syndrome	0.000177	0.0548	CrCbGaD
Bisoprolol—Metoprolol—ABCB1—epilepsy syndrome	0.000149	0.0462	CrCbGaD
Bisoprolol—Propranolol—CYP2C19—epilepsy syndrome	0.000142	0.0441	CrCbGaD
Bisoprolol—Propranolol—CYP2D6—epilepsy syndrome	0.000106	0.0327	CrCbGaD
Bisoprolol—Propranolol—ABCB1—epilepsy syndrome	7.54e-05	0.0233	CrCbGaD
Bisoprolol—Pruritus—Phenytoin—epilepsy syndrome	5.93e-05	0.000201	CcSEcCtD
Bisoprolol—Connective tissue disorder—Topiramate—epilepsy syndrome	5.93e-05	0.000201	CcSEcCtD
Bisoprolol—Nausea—Levetiracetam—epilepsy syndrome	5.93e-05	0.000201	CcSEcCtD
Bisoprolol—Rash—Vigabatrin—epilepsy syndrome	5.92e-05	0.0002	CcSEcCtD
Bisoprolol—Dizziness—Felbamate—epilepsy syndrome	5.92e-05	0.0002	CcSEcCtD
Bisoprolol—Dermatitis—Vigabatrin—epilepsy syndrome	5.91e-05	0.0002	CcSEcCtD
Bisoprolol—Pruritus—Oxcarbazepine—epilepsy syndrome	5.9e-05	0.0002	CcSEcCtD
Bisoprolol—Hypersensitivity—Carbamazepine—epilepsy syndrome	5.9e-05	0.000199	CcSEcCtD
Bisoprolol—Headache—Vigabatrin—epilepsy syndrome	5.88e-05	0.000199	CcSEcCtD
Bisoprolol—Vomiting—Diazepam—epilepsy syndrome	5.88e-05	0.000199	CcSEcCtD
Bisoprolol—Tremor—Gabapentin—epilepsy syndrome	5.85e-05	0.000198	CcSEcCtD
Bisoprolol—Rash—Diazepam—epilepsy syndrome	5.83e-05	0.000197	CcSEcCtD
Bisoprolol—Dermatitis—Diazepam—epilepsy syndrome	5.82e-05	0.000197	CcSEcCtD
Bisoprolol—Visual impairment—Topiramate—epilepsy syndrome	5.81e-05	0.000197	CcSEcCtD
Bisoprolol—Arthralgia—Pregabalin—epilepsy syndrome	5.8e-05	0.000196	CcSEcCtD
Bisoprolol—Chest pain—Pregabalin—epilepsy syndrome	5.8e-05	0.000196	CcSEcCtD
Bisoprolol—Myalgia—Pregabalin—epilepsy syndrome	5.8e-05	0.000196	CcSEcCtD
Bisoprolol—Ill-defined disorder—Gabapentin—epilepsy syndrome	5.79e-05	0.000196	CcSEcCtD
Bisoprolol—Dizziness—Zonisamide—epilepsy syndrome	5.79e-05	0.000196	CcSEcCtD
Bisoprolol—Headache—Diazepam—epilepsy syndrome	5.79e-05	0.000196	CcSEcCtD
Bisoprolol—Anxiety—Pregabalin—epilepsy syndrome	5.78e-05	0.000195	CcSEcCtD
Bisoprolol—Diarrhoea—Clonazepam—epilepsy syndrome	5.77e-05	0.000195	CcSEcCtD
Bisoprolol—Unspecified disorder of skin and subcutaneous tissue—Pregabalin—epilepsy syndrome	5.76e-05	0.000195	CcSEcCtD
Bisoprolol—Hypotension—Valproic Acid—epilepsy syndrome	5.74e-05	0.000194	CcSEcCtD
Bisoprolol—Asthenia—Carbamazepine—epilepsy syndrome	5.74e-05	0.000194	CcSEcCtD
Bisoprolol—Agitation—Gabapentin—epilepsy syndrome	5.74e-05	0.000194	CcSEcCtD
Bisoprolol—Diarrhoea—Phenytoin—epilepsy syndrome	5.74e-05	0.000194	CcSEcCtD
Bisoprolol—Discomfort—Pregabalin—epilepsy syndrome	5.73e-05	0.000194	CcSEcCtD
Bisoprolol—Nausea—Fosphenytoin—epilepsy syndrome	5.72e-05	0.000194	CcSEcCtD
Bisoprolol—Diarrhoea—Oxcarbazepine—epilepsy syndrome	5.71e-05	0.000193	CcSEcCtD
Bisoprolol—Angioedema—Gabapentin—epilepsy syndrome	5.7e-05	0.000193	CcSEcCtD
Bisoprolol—Hypersensitivity—Lamotrigine—epilepsy syndrome	5.7e-05	0.000193	CcSEcCtD
Bisoprolol—Vomiting—Felbamate—epilepsy syndrome	5.69e-05	0.000192	CcSEcCtD
Bisoprolol—Dry mouth—Pregabalin—epilepsy syndrome	5.67e-05	0.000192	CcSEcCtD
Bisoprolol—Pruritus—Carbamazepine—epilepsy syndrome	5.66e-05	0.000192	CcSEcCtD
Bisoprolol—Rash—Felbamate—epilepsy syndrome	5.64e-05	0.000191	CcSEcCtD
Bisoprolol—Eye disorder—Topiramate—epilepsy syndrome	5.64e-05	0.000191	CcSEcCtD
Bisoprolol—Dermatitis—Felbamate—epilepsy syndrome	5.64e-05	0.000191	CcSEcCtD
Bisoprolol—Malaise—Gabapentin—epilepsy syndrome	5.63e-05	0.00019	CcSEcCtD
Bisoprolol—Tinnitus—Topiramate—epilepsy syndrome	5.62e-05	0.00019	CcSEcCtD
Bisoprolol—Vertigo—Gabapentin—epilepsy syndrome	5.61e-05	0.00019	CcSEcCtD
Bisoprolol—Headache—Felbamate—epilepsy syndrome	5.6e-05	0.00019	CcSEcCtD
Bisoprolol—Confusional state—Pregabalin—epilepsy syndrome	5.6e-05	0.00019	CcSEcCtD
Bisoprolol—Musculoskeletal discomfort—Valproic Acid—epilepsy syndrome	5.6e-05	0.000189	CcSEcCtD
Bisoprolol—Flushing—Topiramate—epilepsy syndrome	5.6e-05	0.000189	CcSEcCtD
Bisoprolol—Cardiac disorder—Topiramate—epilepsy syndrome	5.6e-05	0.000189	CcSEcCtD
Bisoprolol—Syncope—Gabapentin—epilepsy syndrome	5.6e-05	0.000189	CcSEcCtD
Bisoprolol—Dizziness—Clonazepam—epilepsy syndrome	5.58e-05	0.000189	CcSEcCtD
Bisoprolol—Nausea—Vigabatrin—epilepsy syndrome	5.58e-05	0.000189	CcSEcCtD
Bisoprolol—Vomiting—Zonisamide—epilepsy syndrome	5.57e-05	0.000188	CcSEcCtD
Bisoprolol—Insomnia—Valproic Acid—epilepsy syndrome	5.56e-05	0.000188	CcSEcCtD
Bisoprolol—Oedema—Pregabalin—epilepsy syndrome	5.56e-05	0.000188	CcSEcCtD
Bisoprolol—Asthenia—Lamotrigine—epilepsy syndrome	5.55e-05	0.000188	CcSEcCtD
Bisoprolol—Dizziness—Phenytoin—epilepsy syndrome	5.54e-05	0.000188	CcSEcCtD
Bisoprolol—Rash—Zonisamide—epilepsy syndrome	5.52e-05	0.000187	CcSEcCtD
Bisoprolol—Infection—Pregabalin—epilepsy syndrome	5.52e-05	0.000187	CcSEcCtD
Bisoprolol—Paraesthesia—Valproic Acid—epilepsy syndrome	5.52e-05	0.000187	CcSEcCtD
Bisoprolol—Palpitations—Gabapentin—epilepsy syndrome	5.52e-05	0.000187	CcSEcCtD
Bisoprolol—Dermatitis—Zonisamide—epilepsy syndrome	5.52e-05	0.000187	CcSEcCtD
Bisoprolol—Dizziness—Oxcarbazepine—epilepsy syndrome	5.51e-05	0.000187	CcSEcCtD
Bisoprolol—Nausea—Diazepam—epilepsy syndrome	5.49e-05	0.000186	CcSEcCtD
Bisoprolol—Loss of consciousness—Gabapentin—epilepsy syndrome	5.49e-05	0.000186	CcSEcCtD
Bisoprolol—Headache—Zonisamide—epilepsy syndrome	5.49e-05	0.000186	CcSEcCtD
Bisoprolol—Dyspnoea—Valproic Acid—epilepsy syndrome	5.48e-05	0.000185	CcSEcCtD
Bisoprolol—Diarrhoea—Carbamazepine—epilepsy syndrome	5.47e-05	0.000185	CcSEcCtD
Bisoprolol—Angiopathy—Topiramate—epilepsy syndrome	5.47e-05	0.000185	CcSEcCtD
Bisoprolol—Pruritus—Lamotrigine—epilepsy syndrome	5.47e-05	0.000185	CcSEcCtD
Bisoprolol—Shock—Pregabalin—epilepsy syndrome	5.47e-05	0.000185	CcSEcCtD
Bisoprolol—Somnolence—Valproic Acid—epilepsy syndrome	5.46e-05	0.000185	CcSEcCtD
Bisoprolol—Nervous system disorder—Pregabalin—epilepsy syndrome	5.45e-05	0.000184	CcSEcCtD
Bisoprolol—Cough—Gabapentin—epilepsy syndrome	5.45e-05	0.000184	CcSEcCtD
Bisoprolol—Thrombocytopenia—Pregabalin—epilepsy syndrome	5.44e-05	0.000184	CcSEcCtD
Bisoprolol—Mediastinal disorder—Topiramate—epilepsy syndrome	5.44e-05	0.000184	CcSEcCtD
Bisoprolol—Tachycardia—Pregabalin—epilepsy syndrome	5.42e-05	0.000183	CcSEcCtD
Bisoprolol—Dyspepsia—Valproic Acid—epilepsy syndrome	5.41e-05	0.000183	CcSEcCtD
Bisoprolol—Skin disorder—Pregabalin—epilepsy syndrome	5.4e-05	0.000183	CcSEcCtD
Bisoprolol—Hyperhidrosis—Pregabalin—epilepsy syndrome	5.37e-05	0.000182	CcSEcCtD
Bisoprolol—Vomiting—Clonazepam—epilepsy syndrome	5.37e-05	0.000182	CcSEcCtD
Bisoprolol—Alopecia—Topiramate—epilepsy syndrome	5.33e-05	0.00018	CcSEcCtD
Bisoprolol—Vomiting—Phenytoin—epilepsy syndrome	5.33e-05	0.00018	CcSEcCtD
Bisoprolol—Rash—Clonazepam—epilepsy syndrome	5.32e-05	0.00018	CcSEcCtD
Bisoprolol—Dermatitis—Clonazepam—epilepsy syndrome	5.32e-05	0.00018	CcSEcCtD
Bisoprolol—Arthralgia—Gabapentin—epilepsy syndrome	5.31e-05	0.00018	CcSEcCtD
Bisoprolol—Myalgia—Gabapentin—epilepsy syndrome	5.31e-05	0.00018	CcSEcCtD
Bisoprolol—Chest pain—Gabapentin—epilepsy syndrome	5.31e-05	0.00018	CcSEcCtD
Bisoprolol—Nausea—Felbamate—epilepsy syndrome	5.31e-05	0.00018	CcSEcCtD
Bisoprolol—Gastrointestinal disorder—Valproic Acid—epilepsy syndrome	5.31e-05	0.00018	CcSEcCtD
Bisoprolol—Vomiting—Oxcarbazepine—epilepsy syndrome	5.3e-05	0.000179	CcSEcCtD
Bisoprolol—Fatigue—Valproic Acid—epilepsy syndrome	5.3e-05	0.000179	CcSEcCtD
Bisoprolol—Anxiety—Gabapentin—epilepsy syndrome	5.3e-05	0.000179	CcSEcCtD
Bisoprolol—Dizziness—Carbamazepine—epilepsy syndrome	5.29e-05	0.000179	CcSEcCtD
Bisoprolol—Diarrhoea—Lamotrigine—epilepsy syndrome	5.29e-05	0.000179	CcSEcCtD
Bisoprolol—Headache—Clonazepam—epilepsy syndrome	5.29e-05	0.000179	CcSEcCtD
Bisoprolol—Rash—Phenytoin—epilepsy syndrome	5.29e-05	0.000179	CcSEcCtD
Bisoprolol—Mental disorder—Topiramate—epilepsy syndrome	5.29e-05	0.000179	CcSEcCtD
Bisoprolol—Dermatitis—Phenytoin—epilepsy syndrome	5.28e-05	0.000179	CcSEcCtD
Bisoprolol—Unspecified disorder of skin and subcutaneous tissue—Gabapentin—epilepsy syndrome	5.28e-05	0.000179	CcSEcCtD
Bisoprolol—Rash—Oxcarbazepine—epilepsy syndrome	5.26e-05	0.000178	CcSEcCtD
Bisoprolol—Pain—Valproic Acid—epilepsy syndrome	5.26e-05	0.000178	CcSEcCtD
Bisoprolol—Constipation—Valproic Acid—epilepsy syndrome	5.26e-05	0.000178	CcSEcCtD
Bisoprolol—Dermatitis—Oxcarbazepine—epilepsy syndrome	5.25e-05	0.000178	CcSEcCtD
Bisoprolol—Headache—Phenytoin—epilepsy syndrome	5.25e-05	0.000178	CcSEcCtD
Bisoprolol—Erythema—Topiramate—epilepsy syndrome	5.25e-05	0.000178	CcSEcCtD
Bisoprolol—Discomfort—Gabapentin—epilepsy syndrome	5.25e-05	0.000178	CcSEcCtD
Bisoprolol—Headache—Oxcarbazepine—epilepsy syndrome	5.22e-05	0.000177	CcSEcCtD
Bisoprolol—Nausea—Zonisamide—epilepsy syndrome	5.2e-05	0.000176	CcSEcCtD
Bisoprolol—Dry mouth—Gabapentin—epilepsy syndrome	5.2e-05	0.000176	CcSEcCtD
Bisoprolol—Hypotension—Pregabalin—epilepsy syndrome	5.19e-05	0.000176	CcSEcCtD
Bisoprolol—Dysgeusia—Topiramate—epilepsy syndrome	5.14e-05	0.000174	CcSEcCtD
Bisoprolol—Confusional state—Gabapentin—epilepsy syndrome	5.14e-05	0.000174	CcSEcCtD
Bisoprolol—Dizziness—Lamotrigine—epilepsy syndrome	5.11e-05	0.000173	CcSEcCtD
Bisoprolol—Oedema—Gabapentin—epilepsy syndrome	5.09e-05	0.000172	CcSEcCtD
Bisoprolol—Vomiting—Carbamazepine—epilepsy syndrome	5.09e-05	0.000172	CcSEcCtD
Bisoprolol—Back pain—Topiramate—epilepsy syndrome	5.08e-05	0.000172	CcSEcCtD
Bisoprolol—Feeling abnormal—Valproic Acid—epilepsy syndrome	5.06e-05	0.000171	CcSEcCtD
Bisoprolol—Musculoskeletal discomfort—Pregabalin—epilepsy syndrome	5.06e-05	0.000171	CcSEcCtD
Bisoprolol—Infection—Gabapentin—epilepsy syndrome	5.06e-05	0.000171	CcSEcCtD
Bisoprolol—Muscle spasms—Topiramate—epilepsy syndrome	5.05e-05	0.000171	CcSEcCtD
Bisoprolol—Rash—Carbamazepine—epilepsy syndrome	5.05e-05	0.000171	CcSEcCtD
Bisoprolol—Dermatitis—Carbamazepine—epilepsy syndrome	5.04e-05	0.000171	CcSEcCtD
Bisoprolol—Gastrointestinal pain—Valproic Acid—epilepsy syndrome	5.03e-05	0.00017	CcSEcCtD
Bisoprolol—Insomnia—Pregabalin—epilepsy syndrome	5.02e-05	0.00017	CcSEcCtD
Bisoprolol—Nausea—Clonazepam—epilepsy syndrome	5.01e-05	0.00017	CcSEcCtD
Bisoprolol—Headache—Carbamazepine—epilepsy syndrome	5.01e-05	0.00017	CcSEcCtD
Bisoprolol—Shock—Gabapentin—epilepsy syndrome	5.01e-05	0.00017	CcSEcCtD
Bisoprolol—Nervous system disorder—Gabapentin—epilepsy syndrome	5e-05	0.000169	CcSEcCtD
Bisoprolol—Paraesthesia—Pregabalin—epilepsy syndrome	4.99e-05	0.000169	CcSEcCtD
Bisoprolol—Thrombocytopenia—Gabapentin—epilepsy syndrome	4.99e-05	0.000169	CcSEcCtD
Bisoprolol—Nausea—Phenytoin—epilepsy syndrome	4.98e-05	0.000168	CcSEcCtD
Bisoprolol—Tachycardia—Gabapentin—epilepsy syndrome	4.97e-05	0.000168	CcSEcCtD
Bisoprolol—Dyspnoea—Pregabalin—epilepsy syndrome	4.95e-05	0.000168	CcSEcCtD
Bisoprolol—Nausea—Oxcarbazepine—epilepsy syndrome	4.95e-05	0.000168	CcSEcCtD
Bisoprolol—Skin disorder—Gabapentin—epilepsy syndrome	4.95e-05	0.000167	CcSEcCtD
Bisoprolol—Somnolence—Pregabalin—epilepsy syndrome	4.94e-05	0.000167	CcSEcCtD
Bisoprolol—Hyperhidrosis—Gabapentin—epilepsy syndrome	4.92e-05	0.000167	CcSEcCtD
Bisoprolol—Tremor—Topiramate—epilepsy syndrome	4.92e-05	0.000166	CcSEcCtD
Bisoprolol—Vomiting—Lamotrigine—epilepsy syndrome	4.92e-05	0.000166	CcSEcCtD
Bisoprolol—Urticaria—Valproic Acid—epilepsy syndrome	4.88e-05	0.000165	CcSEcCtD
Bisoprolol—Rash—Lamotrigine—epilepsy syndrome	4.88e-05	0.000165	CcSEcCtD
Bisoprolol—Ill-defined disorder—Topiramate—epilepsy syndrome	4.87e-05	0.000165	CcSEcCtD
Bisoprolol—Dermatitis—Lamotrigine—epilepsy syndrome	4.87e-05	0.000165	CcSEcCtD
Bisoprolol—Abdominal pain—Valproic Acid—epilepsy syndrome	4.86e-05	0.000164	CcSEcCtD
Bisoprolol—Body temperature increased—Valproic Acid—epilepsy syndrome	4.86e-05	0.000164	CcSEcCtD
Bisoprolol—Headache—Lamotrigine—epilepsy syndrome	4.84e-05	0.000164	CcSEcCtD
Bisoprolol—Agitation—Topiramate—epilepsy syndrome	4.83e-05	0.000163	CcSEcCtD
Bisoprolol—Gastrointestinal disorder—Pregabalin—epilepsy syndrome	4.8e-05	0.000162	CcSEcCtD
Bisoprolol—Fatigue—Pregabalin—epilepsy syndrome	4.79e-05	0.000162	CcSEcCtD
Bisoprolol—Hypotension—Gabapentin—epilepsy syndrome	4.76e-05	0.000161	CcSEcCtD
Bisoprolol—Nausea—Carbamazepine—epilepsy syndrome	4.75e-05	0.000161	CcSEcCtD
Bisoprolol—Pain—Pregabalin—epilepsy syndrome	4.75e-05	0.000161	CcSEcCtD
Bisoprolol—Constipation—Pregabalin—epilepsy syndrome	4.75e-05	0.000161	CcSEcCtD
Bisoprolol—Malaise—Topiramate—epilepsy syndrome	4.74e-05	0.00016	CcSEcCtD
Bisoprolol—Vertigo—Topiramate—epilepsy syndrome	4.72e-05	0.00016	CcSEcCtD
Bisoprolol—Syncope—Topiramate—epilepsy syndrome	4.71e-05	0.000159	CcSEcCtD
Bisoprolol—Musculoskeletal discomfort—Gabapentin—epilepsy syndrome	4.64e-05	0.000157	CcSEcCtD
Bisoprolol—Palpitations—Topiramate—epilepsy syndrome	4.64e-05	0.000157	CcSEcCtD
Bisoprolol—Loss of consciousness—Topiramate—epilepsy syndrome	4.62e-05	0.000156	CcSEcCtD
Bisoprolol—Insomnia—Gabapentin—epilepsy syndrome	4.61e-05	0.000156	CcSEcCtD
Bisoprolol—Nausea—Lamotrigine—epilepsy syndrome	4.59e-05	0.000155	CcSEcCtD
Bisoprolol—Cough—Topiramate—epilepsy syndrome	4.58e-05	0.000155	CcSEcCtD
Bisoprolol—Feeling abnormal—Pregabalin—epilepsy syndrome	4.58e-05	0.000155	CcSEcCtD
Bisoprolol—Paraesthesia—Gabapentin—epilepsy syndrome	4.57e-05	0.000155	CcSEcCtD
Bisoprolol—Gastrointestinal pain—Pregabalin—epilepsy syndrome	4.54e-05	0.000154	CcSEcCtD
Bisoprolol—Dyspnoea—Gabapentin—epilepsy syndrome	4.54e-05	0.000154	CcSEcCtD
Bisoprolol—Somnolence—Gabapentin—epilepsy syndrome	4.53e-05	0.000153	CcSEcCtD
Bisoprolol—Hypersensitivity—Valproic Acid—epilepsy syndrome	4.53e-05	0.000153	CcSEcCtD
Bisoprolol—Dyspepsia—Gabapentin—epilepsy syndrome	4.48e-05	0.000152	CcSEcCtD
Bisoprolol—Chest pain—Topiramate—epilepsy syndrome	4.47e-05	0.000151	CcSEcCtD
Bisoprolol—Myalgia—Topiramate—epilepsy syndrome	4.47e-05	0.000151	CcSEcCtD
Bisoprolol—Arthralgia—Topiramate—epilepsy syndrome	4.47e-05	0.000151	CcSEcCtD
Bisoprolol—Anxiety—Topiramate—epilepsy syndrome	4.46e-05	0.000151	CcSEcCtD
Bisoprolol—Unspecified disorder of skin and subcutaneous tissue—Topiramate—epilepsy syndrome	4.44e-05	0.00015	CcSEcCtD
Bisoprolol—Discomfort—Topiramate—epilepsy syndrome	4.42e-05	0.000149	CcSEcCtD
Bisoprolol—Urticaria—Pregabalin—epilepsy syndrome	4.41e-05	0.000149	CcSEcCtD
Bisoprolol—Asthenia—Valproic Acid—epilepsy syndrome	4.41e-05	0.000149	CcSEcCtD
Bisoprolol—Gastrointestinal disorder—Gabapentin—epilepsy syndrome	4.4e-05	0.000149	CcSEcCtD
Bisoprolol—Fatigue—Gabapentin—epilepsy syndrome	4.39e-05	0.000149	CcSEcCtD
Bisoprolol—Abdominal pain—Pregabalin—epilepsy syndrome	4.39e-05	0.000149	CcSEcCtD
Bisoprolol—Body temperature increased—Pregabalin—epilepsy syndrome	4.39e-05	0.000149	CcSEcCtD
Bisoprolol—Dry mouth—Topiramate—epilepsy syndrome	4.37e-05	0.000148	CcSEcCtD
Bisoprolol—Constipation—Gabapentin—epilepsy syndrome	4.36e-05	0.000147	CcSEcCtD
Bisoprolol—Pain—Gabapentin—epilepsy syndrome	4.36e-05	0.000147	CcSEcCtD
Bisoprolol—Pruritus—Valproic Acid—epilepsy syndrome	4.35e-05	0.000147	CcSEcCtD
Bisoprolol—Confusional state—Topiramate—epilepsy syndrome	4.32e-05	0.000146	CcSEcCtD
Bisoprolol—Oedema—Topiramate—epilepsy syndrome	4.29e-05	0.000145	CcSEcCtD
Bisoprolol—Infection—Topiramate—epilepsy syndrome	4.26e-05	0.000144	CcSEcCtD
Bisoprolol—Shock—Topiramate—epilepsy syndrome	4.22e-05	0.000143	CcSEcCtD
Bisoprolol—Diarrhoea—Valproic Acid—epilepsy syndrome	4.2e-05	0.000142	CcSEcCtD
Bisoprolol—Nervous system disorder—Topiramate—epilepsy syndrome	4.2e-05	0.000142	CcSEcCtD
Bisoprolol—Feeling abnormal—Gabapentin—epilepsy syndrome	4.2e-05	0.000142	CcSEcCtD
Bisoprolol—Thrombocytopenia—Topiramate—epilepsy syndrome	4.2e-05	0.000142	CcSEcCtD
Bisoprolol—Tachycardia—Topiramate—epilepsy syndrome	4.18e-05	0.000142	CcSEcCtD
Bisoprolol—Gastrointestinal pain—Gabapentin—epilepsy syndrome	4.17e-05	0.000141	CcSEcCtD
Bisoprolol—Skin disorder—Topiramate—epilepsy syndrome	4.16e-05	0.000141	CcSEcCtD
Bisoprolol—Hyperhidrosis—Topiramate—epilepsy syndrome	4.14e-05	0.00014	CcSEcCtD
Bisoprolol—Hypersensitivity—Pregabalin—epilepsy syndrome	4.09e-05	0.000139	CcSEcCtD
Bisoprolol—Dizziness—Valproic Acid—epilepsy syndrome	4.06e-05	0.000138	CcSEcCtD
Bisoprolol—Urticaria—Gabapentin—epilepsy syndrome	4.05e-05	0.000137	CcSEcCtD
Bisoprolol—Body temperature increased—Gabapentin—epilepsy syndrome	4.03e-05	0.000136	CcSEcCtD
Bisoprolol—Abdominal pain—Gabapentin—epilepsy syndrome	4.03e-05	0.000136	CcSEcCtD
Bisoprolol—Hypotension—Topiramate—epilepsy syndrome	4e-05	0.000136	CcSEcCtD
Bisoprolol—Asthenia—Pregabalin—epilepsy syndrome	3.99e-05	0.000135	CcSEcCtD
Bisoprolol—Pruritus—Pregabalin—epilepsy syndrome	3.93e-05	0.000133	CcSEcCtD
Bisoprolol—Vomiting—Valproic Acid—epilepsy syndrome	3.91e-05	0.000132	CcSEcCtD
Bisoprolol—Musculoskeletal discomfort—Topiramate—epilepsy syndrome	3.9e-05	0.000132	CcSEcCtD
Bisoprolol—Insomnia—Topiramate—epilepsy syndrome	3.88e-05	0.000131	CcSEcCtD
Bisoprolol—Rash—Valproic Acid—epilepsy syndrome	3.87e-05	0.000131	CcSEcCtD
Bisoprolol—Dermatitis—Valproic Acid—epilepsy syndrome	3.87e-05	0.000131	CcSEcCtD
Bisoprolol—Headache—Valproic Acid—epilepsy syndrome	3.85e-05	0.00013	CcSEcCtD
Bisoprolol—Paraesthesia—Topiramate—epilepsy syndrome	3.85e-05	0.00013	CcSEcCtD
Bisoprolol—Dyspnoea—Topiramate—epilepsy syndrome	3.82e-05	0.000129	CcSEcCtD
Bisoprolol—Somnolence—Topiramate—epilepsy syndrome	3.81e-05	0.000129	CcSEcCtD
Bisoprolol—Diarrhoea—Pregabalin—epilepsy syndrome	3.8e-05	0.000129	CcSEcCtD
Bisoprolol—Dyspepsia—Topiramate—epilepsy syndrome	3.77e-05	0.000128	CcSEcCtD
Bisoprolol—Hypersensitivity—Gabapentin—epilepsy syndrome	3.75e-05	0.000127	CcSEcCtD
Bisoprolol—Gastrointestinal disorder—Topiramate—epilepsy syndrome	3.7e-05	0.000125	CcSEcCtD
Bisoprolol—Fatigue—Topiramate—epilepsy syndrome	3.7e-05	0.000125	CcSEcCtD
Bisoprolol—Dizziness—Pregabalin—epilepsy syndrome	3.67e-05	0.000124	CcSEcCtD
Bisoprolol—Pain—Topiramate—epilepsy syndrome	3.67e-05	0.000124	CcSEcCtD
Bisoprolol—Constipation—Topiramate—epilepsy syndrome	3.67e-05	0.000124	CcSEcCtD
Bisoprolol—Asthenia—Gabapentin—epilepsy syndrome	3.66e-05	0.000124	CcSEcCtD
Bisoprolol—Nausea—Valproic Acid—epilepsy syndrome	3.65e-05	0.000124	CcSEcCtD
Bisoprolol—Pruritus—Gabapentin—epilepsy syndrome	3.6e-05	0.000122	CcSEcCtD
Bisoprolol—Vomiting—Pregabalin—epilepsy syndrome	3.53e-05	0.00012	CcSEcCtD
Bisoprolol—Feeling abnormal—Topiramate—epilepsy syndrome	3.53e-05	0.00012	CcSEcCtD
Bisoprolol—Gastrointestinal pain—Topiramate—epilepsy syndrome	3.5e-05	0.000119	CcSEcCtD
Bisoprolol—Rash—Pregabalin—epilepsy syndrome	3.5e-05	0.000119	CcSEcCtD
Bisoprolol—Dermatitis—Pregabalin—epilepsy syndrome	3.5e-05	0.000118	CcSEcCtD
Bisoprolol—Diarrhoea—Gabapentin—epilepsy syndrome	3.49e-05	0.000118	CcSEcCtD
Bisoprolol—Headache—Pregabalin—epilepsy syndrome	3.48e-05	0.000118	CcSEcCtD
Bisoprolol—Urticaria—Topiramate—epilepsy syndrome	3.4e-05	0.000115	CcSEcCtD
Bisoprolol—Abdominal pain—Topiramate—epilepsy syndrome	3.39e-05	0.000115	CcSEcCtD
Bisoprolol—Body temperature increased—Topiramate—epilepsy syndrome	3.39e-05	0.000115	CcSEcCtD
Bisoprolol—Dizziness—Gabapentin—epilepsy syndrome	3.37e-05	0.000114	CcSEcCtD
Bisoprolol—Nausea—Pregabalin—epilepsy syndrome	3.3e-05	0.000112	CcSEcCtD
Bisoprolol—Vomiting—Gabapentin—epilepsy syndrome	3.24e-05	0.00011	CcSEcCtD
Bisoprolol—Rash—Gabapentin—epilepsy syndrome	3.21e-05	0.000109	CcSEcCtD
Bisoprolol—Dermatitis—Gabapentin—epilepsy syndrome	3.21e-05	0.000109	CcSEcCtD
Bisoprolol—Headache—Gabapentin—epilepsy syndrome	3.19e-05	0.000108	CcSEcCtD
Bisoprolol—Hypersensitivity—Topiramate—epilepsy syndrome	3.16e-05	0.000107	CcSEcCtD
Bisoprolol—Asthenia—Topiramate—epilepsy syndrome	3.08e-05	0.000104	CcSEcCtD
Bisoprolol—Pruritus—Topiramate—epilepsy syndrome	3.03e-05	0.000103	CcSEcCtD
Bisoprolol—Nausea—Gabapentin—epilepsy syndrome	3.03e-05	0.000102	CcSEcCtD
Bisoprolol—Diarrhoea—Topiramate—epilepsy syndrome	2.93e-05	9.92e-05	CcSEcCtD
Bisoprolol—Dizziness—Topiramate—epilepsy syndrome	2.83e-05	9.59e-05	CcSEcCtD
Bisoprolol—Vomiting—Topiramate—epilepsy syndrome	2.73e-05	9.22e-05	CcSEcCtD
Bisoprolol—Rash—Topiramate—epilepsy syndrome	2.7e-05	9.14e-05	CcSEcCtD
Bisoprolol—Dermatitis—Topiramate—epilepsy syndrome	2.7e-05	9.14e-05	CcSEcCtD
Bisoprolol—Headache—Topiramate—epilepsy syndrome	2.69e-05	9.09e-05	CcSEcCtD
Bisoprolol—Nausea—Topiramate—epilepsy syndrome	2.55e-05	8.61e-05	CcSEcCtD
Bisoprolol—CYP2D6—Metabolism—UPB1—epilepsy syndrome	2.02e-05	0.000316	CbGpPWpGaD
Bisoprolol—CYP2D6—Metabolism—NEU1—epilepsy syndrome	2.02e-05	0.000316	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling Pathways—CX3CR1—epilepsy syndrome	1.98e-05	0.00031	CbGpPWpGaD
Bisoprolol—ADRB2—GPCR downstream signaling—AVP—epilepsy syndrome	1.98e-05	0.00031	CbGpPWpGaD
Bisoprolol—CYP2D6—Metabolism—HSD17B4—epilepsy syndrome	1.94e-05	0.000304	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling Pathways—BDKRB1—epilepsy syndrome	1.94e-05	0.000304	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling Pathways—CHRM2—epilepsy syndrome	1.94e-05	0.000304	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling Pathways—CX3CL1—epilepsy syndrome	1.94e-05	0.000304	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling Pathways—CX3CR1—epilepsy syndrome	1.94e-05	0.000303	CbGpPWpGaD
Bisoprolol—CYP3A4—Metabolism—FAR1—epilepsy syndrome	1.91e-05	0.000298	CbGpPWpGaD
Bisoprolol—CYP3A4—Metabolism—PDXK—epilepsy syndrome	1.91e-05	0.000298	CbGpPWpGaD
Bisoprolol—CYP3A4—Metabolism—CERS1—epilepsy syndrome	1.91e-05	0.000298	CbGpPWpGaD
Bisoprolol—CYP3A4—Metabolism—L2HGDH—epilepsy syndrome	1.91e-05	0.000298	CbGpPWpGaD
Bisoprolol—CYP3A4—Metabolism—ADK—epilepsy syndrome	1.91e-05	0.000298	CbGpPWpGaD
Bisoprolol—CYP3A4—Metabolism—GLUD1—epilepsy syndrome	1.91e-05	0.000298	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling Pathways—CHRM2—epilepsy syndrome	1.9e-05	0.000297	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling Pathways—BDKRB1—epilepsy syndrome	1.9e-05	0.000297	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling Pathways—CX3CL1—epilepsy syndrome	1.9e-05	0.000297	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling by GPCR—CDC42—epilepsy syndrome	1.9e-05	0.000297	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling Pathways—GABBR1—epilepsy syndrome	1.89e-05	0.000296	CbGpPWpGaD
Bisoprolol—CYP2D6—Metabolism—GBE1—epilepsy syndrome	1.88e-05	0.000294	CbGpPWpGaD
Bisoprolol—CYP2D6—Metabolism—PPP1R3C—epilepsy syndrome	1.88e-05	0.000294	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling by GPCR—CDC42—epilepsy syndrome	1.86e-05	0.00029	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling Pathways—GABBR1—epilepsy syndrome	1.85e-05	0.000289	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling by GPCR—AVP—epilepsy syndrome	1.84e-05	0.000287	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling Pathways—HRH3—epilepsy syndrome	1.81e-05	0.000283	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling by GPCR—AVP—epilepsy syndrome	1.8e-05	0.000281	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling Pathways—OPRM1—epilepsy syndrome	1.78e-05	0.000279	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling Pathways—HRH3—epilepsy syndrome	1.77e-05	0.000277	CbGpPWpGaD
Bisoprolol—CYP2D6—Metabolism—ASAH1—epilepsy syndrome	1.77e-05	0.000276	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling Pathways—OPRM1—epilepsy syndrome	1.74e-05	0.000273	CbGpPWpGaD
Bisoprolol—CYP3A4—Metabolism—EPM2A—epilepsy syndrome	1.74e-05	0.000273	CbGpPWpGaD
Bisoprolol—CYP3A4—Metabolism—GAMT—epilepsy syndrome	1.74e-05	0.000273	CbGpPWpGaD
Bisoprolol—CYP3A4—Metabolism—PNPO—epilepsy syndrome	1.74e-05	0.000273	CbGpPWpGaD
Bisoprolol—CYP3A4—Metabolism—NHLRC1—epilepsy syndrome	1.74e-05	0.000273	CbGpPWpGaD
Bisoprolol—ADRB1—GPCR downstream signaling—CCR5—epilepsy syndrome	1.72e-05	0.000269	CbGpPWpGaD
Bisoprolol—CYP2D6—Metabolism—STXBP1—epilepsy syndrome	1.72e-05	0.000269	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling Pathways—CCR3—epilepsy syndrome	1.68e-05	0.000264	CbGpPWpGaD
Bisoprolol—ADRB1—GPCR downstream signaling—HTR2A—epilepsy syndrome	1.68e-05	0.000263	CbGpPWpGaD
Bisoprolol—ADRB2—GPCR downstream signaling—CCR5—epilepsy syndrome	1.68e-05	0.000263	CbGpPWpGaD
Bisoprolol—CYP2D6—Metabolism—NT5E—epilepsy syndrome	1.67e-05	0.000262	CbGpPWpGaD
Bisoprolol—CYP2D6—Metabolism—ALAD—epilepsy syndrome	1.67e-05	0.000262	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling Pathways—CCR3—epilepsy syndrome	1.65e-05	0.000258	CbGpPWpGaD
Bisoprolol—ADRB2—GPCR downstream signaling—HTR2A—epilepsy syndrome	1.65e-05	0.000258	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling Pathways—NPY—epilepsy syndrome	1.64e-05	0.000257	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling Pathways—ATP2A2—epilepsy syndrome	1.64e-05	0.000257	CbGpPWpGaD
Bisoprolol—CYP3A4—Metabolism—QDPR—epilepsy syndrome	1.62e-05	0.000254	CbGpPWpGaD
Bisoprolol—CYP3A4—Metabolism—CA4—epilepsy syndrome	1.62e-05	0.000254	CbGpPWpGaD
Bisoprolol—CYP3A4—Biological oxidations—POMC—epilepsy syndrome	1.62e-05	0.000253	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling Pathways—NPY—epilepsy syndrome	1.61e-05	0.000251	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling Pathways—ATP2A2—epilepsy syndrome	1.61e-05	0.000251	CbGpPWpGaD
Bisoprolol—ADRB1—GPCR downstream signaling—AGT—epilepsy syndrome	1.6e-05	0.00025	CbGpPWpGaD
Bisoprolol—CYP2D6—Metabolism—ALDH7A1—epilepsy syndrome	1.6e-05	0.00025	CbGpPWpGaD
Bisoprolol—CYP2D6—Metabolism—CACNA1A—epilepsy syndrome	1.6e-05	0.00025	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling Pathways—OXT—epilepsy syndrome	1.58e-05	0.000248	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling Pathways—CXCL2—epilepsy syndrome	1.58e-05	0.000248	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling Pathways—CRH—epilepsy syndrome	1.58e-05	0.000248	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling Pathways—HSPB1—epilepsy syndrome	1.58e-05	0.000248	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling Pathways—CCL3—epilepsy syndrome	1.58e-05	0.000248	CbGpPWpGaD
Bisoprolol—CYP2D6—Metabolism—ST3GAL3—epilepsy syndrome	1.56e-05	0.000245	CbGpPWpGaD
Bisoprolol—ADRB2—GPCR downstream signaling—AGT—epilepsy syndrome	1.56e-05	0.000244	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling by GPCR—CCR5—epilepsy syndrome	1.56e-05	0.000244	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling Pathways—CCL3—epilepsy syndrome	1.55e-05	0.000242	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling Pathways—OXT—epilepsy syndrome	1.55e-05	0.000242	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling Pathways—CXCL2—epilepsy syndrome	1.55e-05	0.000242	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling Pathways—HSPB1—epilepsy syndrome	1.55e-05	0.000242	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling Pathways—CRH—epilepsy syndrome	1.55e-05	0.000242	CbGpPWpGaD
Bisoprolol—CYP2D6—Metabolism—ADSL—epilepsy syndrome	1.53e-05	0.00024	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling by GPCR—HTR2A—epilepsy syndrome	1.53e-05	0.000239	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling by GPCR—CCR5—epilepsy syndrome	1.53e-05	0.000239	CbGpPWpGaD
Bisoprolol—CYP3A4—Metabolism—COX3—epilepsy syndrome	1.52e-05	0.000238	CbGpPWpGaD
Bisoprolol—CYP2D6—Metabolism—GLUL—epilepsy syndrome	1.5e-05	0.000235	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling by GPCR—HTR2A—epilepsy syndrome	1.5e-05	0.000234	CbGpPWpGaD
Bisoprolol—ADRB1—GPCR downstream signaling—PRKCB—epilepsy syndrome	1.48e-05	0.000231	CbGpPWpGaD
Bisoprolol—CYP2D6—Metabolism—CACNA1D—epilepsy syndrome	1.47e-05	0.000231	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling Pathways—TSC1—epilepsy syndrome	1.47e-05	0.00023	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling Pathways—PTK2B—epilepsy syndrome	1.47e-05	0.00023	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling by GPCR—AGT—epilepsy syndrome	1.45e-05	0.000227	CbGpPWpGaD
Bisoprolol—CYP3A4—Metabolism—PFKL—epilepsy syndrome	1.44e-05	0.000226	CbGpPWpGaD
Bisoprolol—CYP3A4—Metabolism—CACNA2D2—epilepsy syndrome	1.44e-05	0.000226	CbGpPWpGaD
Bisoprolol—CYP3A4—Metabolism—SLCO1A2—epilepsy syndrome	1.44e-05	0.000226	CbGpPWpGaD
Bisoprolol—CYP3A4—Metabolism—KCNB1—epilepsy syndrome	1.44e-05	0.000226	CbGpPWpGaD
Bisoprolol—CYP3A4—Metabolism—SLC6A8—epilepsy syndrome	1.44e-05	0.000226	CbGpPWpGaD
Bisoprolol—ADRB2—GPCR downstream signaling—PRKCB—epilepsy syndrome	1.44e-05	0.000226	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling Pathways—TSC1—epilepsy syndrome	1.44e-05	0.000225	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling Pathways—PTK2B—epilepsy syndrome	1.44e-05	0.000225	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling Pathways—SST—epilepsy syndrome	1.43e-05	0.000224	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling Pathways—CCR2—epilepsy syndrome	1.43e-05	0.000224	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling Pathways—NTRK2—epilepsy syndrome	1.43e-05	0.000224	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling Pathways—DUSP6—epilepsy syndrome	1.42e-05	0.000222	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling by GPCR—AGT—epilepsy syndrome	1.42e-05	0.000222	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling Pathways—ADRA2A—epilepsy syndrome	1.4e-05	0.000219	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling Pathways—CCR2—epilepsy syndrome	1.4e-05	0.000219	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling Pathways—SST—epilepsy syndrome	1.4e-05	0.000219	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling Pathways—NTRK2—epilepsy syndrome	1.4e-05	0.000219	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling Pathways—PLAT—epilepsy syndrome	1.4e-05	0.000218	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling Pathways—DUSP6—epilepsy syndrome	1.39e-05	0.000217	CbGpPWpGaD
Bisoprolol—CYP2D6—Metabolism—TXNRD1—epilepsy syndrome	1.38e-05	0.000216	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling Pathways—ADRA2A—epilepsy syndrome	1.37e-05	0.000215	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling Pathways—PLAT—epilepsy syndrome	1.37e-05	0.000214	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling Pathways—CXCL12—epilepsy syndrome	1.35e-05	0.000211	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling Pathways—BDKRB2—epilepsy syndrome	1.35e-05	0.000211	CbGpPWpGaD
Bisoprolol—ADRB1—GPCR downstream signaling—POMC—epilepsy syndrome	1.34e-05	0.00021	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling by GPCR—PRKCB—epilepsy syndrome	1.34e-05	0.00021	CbGpPWpGaD
Bisoprolol—CYP2D6—Metabolism—AQP1—epilepsy syndrome	1.34e-05	0.000209	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling by GPCR—IL6ST—epilepsy syndrome	1.33e-05	0.000209	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling Pathways—JUNB—epilepsy syndrome	1.32e-05	0.000207	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling Pathways—CNR1—epilepsy syndrome	1.32e-05	0.000207	CbGpPWpGaD
Bisoprolol—CYP3A4—Metabolism—UPB1—epilepsy syndrome	1.32e-05	0.000207	CbGpPWpGaD
Bisoprolol—CYP3A4—Metabolism—ATIC—epilepsy syndrome	1.32e-05	0.000207	CbGpPWpGaD
Bisoprolol—CYP3A4—Metabolism—NEU1—epilepsy syndrome	1.32e-05	0.000207	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling Pathways—CXCL12—epilepsy syndrome	1.32e-05	0.000206	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling Pathways—BDKRB2—epilepsy syndrome	1.32e-05	0.000206	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling Pathways—PLCB1—epilepsy syndrome	1.32e-05	0.000206	CbGpPWpGaD
Bisoprolol—ADRB2—GPCR downstream signaling—POMC—epilepsy syndrome	1.32e-05	0.000206	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling by GPCR—PRKCB—epilepsy syndrome	1.31e-05	0.000205	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling by GPCR—IL6ST—epilepsy syndrome	1.31e-05	0.000204	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling Pathways—CNR1—epilepsy syndrome	1.29e-05	0.000202	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling Pathways—JUNB—epilepsy syndrome	1.29e-05	0.000202	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling Pathways—HTR7—epilepsy syndrome	1.29e-05	0.000202	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling Pathways—PLCB1—epilepsy syndrome	1.29e-05	0.000202	CbGpPWpGaD
Bisoprolol—CYP3A4—Metabolism—HSD17B4—epilepsy syndrome	1.27e-05	0.000199	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling Pathways—HTR7—epilepsy syndrome	1.26e-05	0.000197	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling Pathways—HBEGF—epilepsy syndrome	1.25e-05	0.000196	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling Pathways—AKT3—epilepsy syndrome	1.23e-05	0.000192	CbGpPWpGaD
Bisoprolol—CYP3A4—Metabolism—PPP1R3C—epilepsy syndrome	1.23e-05	0.000192	CbGpPWpGaD
Bisoprolol—CYP3A4—Metabolism—GBE1—epilepsy syndrome	1.23e-05	0.000192	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling Pathways—HBEGF—epilepsy syndrome	1.22e-05	0.000192	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling by GPCR—POMC—epilepsy syndrome	1.22e-05	0.000191	CbGpPWpGaD
Bisoprolol—CYP2D6—Metabolism—KCNJ11—epilepsy syndrome	1.21e-05	0.000189	CbGpPWpGaD
Bisoprolol—CYP2D6—Metabolism—CHRM3—epilepsy syndrome	1.21e-05	0.000189	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling Pathways—AKT3—epilepsy syndrome	1.2e-05	0.000188	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling Pathways—ADAM10—epilepsy syndrome	1.2e-05	0.000188	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling by GPCR—CCL2—epilepsy syndrome	1.19e-05	0.000187	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling by GPCR—POMC—epilepsy syndrome	1.19e-05	0.000187	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling Pathways—ADAM10—epilepsy syndrome	1.17e-05	0.000184	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling by GPCR—CCL2—epilepsy syndrome	1.17e-05	0.000183	CbGpPWpGaD
Bisoprolol—CYP3A4—Metabolism—ASAH1—epilepsy syndrome	1.15e-05	0.000181	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling Pathways—S100B—epilepsy syndrome	1.13e-05	0.000178	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling Pathways—SOCS3—epilepsy syndrome	1.12e-05	0.000176	CbGpPWpGaD
Bisoprolol—CYP3A4—Metabolism—STXBP1—epilepsy syndrome	1.12e-05	0.000176	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling Pathways—CDC42—epilepsy syndrome	1.12e-05	0.000175	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling Pathways—S100B—epilepsy syndrome	1.11e-05	0.000174	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling Pathways—SOCS3—epilepsy syndrome	1.1e-05	0.000172	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling Pathways—CDC42—epilepsy syndrome	1.1e-05	0.000172	CbGpPWpGaD
Bisoprolol—CYP3A4—Metabolism—NT5E—epilepsy syndrome	1.09e-05	0.000171	CbGpPWpGaD
Bisoprolol—CYP3A4—Metabolism—ALAD—epilepsy syndrome	1.09e-05	0.000171	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling Pathways—AVP—epilepsy syndrome	1.09e-05	0.00017	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling Pathways—AVP—epilepsy syndrome	1.06e-05	0.000166	CbGpPWpGaD
Bisoprolol—CYP3A4—Metabolism—ALDH7A1—epilepsy syndrome	1.04e-05	0.000163	CbGpPWpGaD
Bisoprolol—CYP3A4—Metabolism—CACNA1A—epilepsy syndrome	1.04e-05	0.000163	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling Pathways—HES1—epilepsy syndrome	1.03e-05	0.000161	CbGpPWpGaD
Bisoprolol—CYP3A4—Metabolism—ST3GAL3—epilepsy syndrome	1.02e-05	0.00016	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling Pathways—HES1—epilepsy syndrome	1e-05	0.000157	CbGpPWpGaD
Bisoprolol—CYP3A4—Metabolism—ADSL—epilepsy syndrome	1e-05	0.000157	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling Pathways—FYN—epilepsy syndrome	9.98e-06	0.000156	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling Pathways—H2AFX—epilepsy syndrome	9.94e-06	0.000156	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling Pathways—MEF2C—epilepsy syndrome	9.93e-06	0.000155	CbGpPWpGaD
Bisoprolol—CYP2D6—Metabolism—ABCG2—epilepsy syndrome	9.87e-06	0.000154	CbGpPWpGaD
Bisoprolol—CYP3A4—Metabolism—GLUL—epilepsy syndrome	9.82e-06	0.000154	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling Pathways—FYN—epilepsy syndrome	9.76e-06	0.000153	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling Pathways—H2AFX—epilepsy syndrome	9.73e-06	0.000152	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling Pathways—MEF2C—epilepsy syndrome	9.71e-06	0.000152	CbGpPWpGaD
Bisoprolol—CYP3A4—Metabolism—CACNA1D—epilepsy syndrome	9.64e-06	0.000151	CbGpPWpGaD
Bisoprolol—CYP2D6—Metabolism—CYP2C19—epilepsy syndrome	9.62e-06	0.00015	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling Pathways—YWHAZ—epilepsy syndrome	9.59e-06	0.00015	CbGpPWpGaD
Bisoprolol—CYP2D6—Metabolism—CYP11A1—epilepsy syndrome	9.56e-06	0.00015	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling Pathways—NGF—epilepsy syndrome	9.49e-06	0.000148	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling Pathways—YWHAZ—epilepsy syndrome	9.39e-06	0.000147	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling Pathways—NGF—epilepsy syndrome	9.28e-06	0.000145	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling Pathways—CCR5—epilepsy syndrome	9.23e-06	0.000144	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling Pathways—HTR2A—epilepsy syndrome	9.03e-06	0.000141	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling Pathways—CCR5—epilepsy syndrome	9.03e-06	0.000141	CbGpPWpGaD
Bisoprolol—CYP3A4—Metabolism—TXNRD1—epilepsy syndrome	9.01e-06	0.000141	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling Pathways—HTR2A—epilepsy syndrome	8.83e-06	0.000138	CbGpPWpGaD
Bisoprolol—CYP3A4—Metabolism—AQP1—epilepsy syndrome	8.75e-06	0.000137	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling Pathways—TSC2—epilepsy syndrome	8.58e-06	0.000134	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling Pathways—AGT—epilepsy syndrome	8.57e-06	0.000134	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling Pathways—APOE—epilepsy syndrome	8.4e-06	0.000131	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling Pathways—TSC2—epilepsy syndrome	8.39e-06	0.000131	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling Pathways—AGT—epilepsy syndrome	8.38e-06	0.000131	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling Pathways—KDR—epilepsy syndrome	8.23e-06	0.000129	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling Pathways—APOE—epilepsy syndrome	8.21e-06	0.000129	CbGpPWpGaD
Bisoprolol—CYP2D6—Metabolism—ADRA2A—epilepsy syndrome	8.21e-06	0.000128	CbGpPWpGaD
Bisoprolol—CYP2D6—Metabolism—BCHE—epilepsy syndrome	8.18e-06	0.000128	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling Pathways—KDR—epilepsy syndrome	8.05e-06	0.000126	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling Pathways—PRKCB—epilepsy syndrome	7.92e-06	0.000124	CbGpPWpGaD
Bisoprolol—CYP3A4—Metabolism—CHRM3—epilepsy syndrome	7.91e-06	0.000124	CbGpPWpGaD
Bisoprolol—CYP3A4—Metabolism—KCNJ11—epilepsy syndrome	7.91e-06	0.000124	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling Pathways—IL6ST—epilepsy syndrome	7.89e-06	0.000123	CbGpPWpGaD
Bisoprolol—CYP2D6—Metabolism—SLC2A1—epilepsy syndrome	7.8e-06	0.000122	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling Pathways—PRKCB—epilepsy syndrome	7.75e-06	0.000121	CbGpPWpGaD
Bisoprolol—CYP2D6—Metabolism—PLCB1—epilepsy syndrome	7.71e-06	0.000121	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling Pathways—IL6ST—epilepsy syndrome	7.71e-06	0.000121	CbGpPWpGaD
Bisoprolol—CYP2D6—Metabolism—TH—epilepsy syndrome	7.69e-06	0.00012	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling Pathways—POMC—epilepsy syndrome	7.21e-06	0.000113	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling Pathways—CCL2—epilepsy syndrome	7.06e-06	0.00011	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling Pathways—POMC—epilepsy syndrome	7.06e-06	0.00011	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling Pathways—CCL2—epilepsy syndrome	6.9e-06	0.000108	CbGpPWpGaD
Bisoprolol—CYP3A4—Metabolism—ABCG2—epilepsy syndrome	6.45e-06	0.000101	CbGpPWpGaD
Bisoprolol—CYP2D6—Metabolism—HMOX1—epilepsy syndrome	6.42e-06	0.0001	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling Pathways—FGF2—epilepsy syndrome	6.38e-06	9.98e-05	CbGpPWpGaD
Bisoprolol—CYP2D6—Metabolism—CAT—epilepsy syndrome	6.33e-06	9.91e-05	CbGpPWpGaD
Bisoprolol—CYP3A4—Metabolism—CYP2C19—epilepsy syndrome	6.29e-06	9.84e-05	CbGpPWpGaD
Bisoprolol—CYP3A4—Metabolism—CYP11A1—epilepsy syndrome	6.25e-06	9.78e-05	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling Pathways—FGF2—epilepsy syndrome	6.24e-06	9.76e-05	CbGpPWpGaD
Bisoprolol—CYP2D6—Metabolism—ABCB1—epilepsy syndrome	6.16e-06	9.64e-05	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling Pathways—RELA—epilepsy syndrome	5.92e-06	9.26e-05	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling Pathways—MTOR—epilepsy syndrome	5.81e-06	9.08e-05	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling Pathways—RELA—epilepsy syndrome	5.79e-06	9.06e-05	CbGpPWpGaD
Bisoprolol—CYP2D6—Metabolism—GPX1—epilepsy syndrome	5.73e-06	8.96e-05	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling Pathways—MTOR—epilepsy syndrome	5.68e-06	8.89e-05	CbGpPWpGaD
Bisoprolol—CYP3A4—Metabolism—CYP2D6—epilepsy syndrome	5.64e-06	8.82e-05	CbGpPWpGaD
Bisoprolol—ADRB1—GPCR downstream signaling—AKT1—epilepsy syndrome	5.39e-06	8.43e-05	CbGpPWpGaD
Bisoprolol—CYP3A4—Metabolism—ADRA2A—epilepsy syndrome	5.37e-06	8.4e-05	CbGpPWpGaD
Bisoprolol—CYP3A4—Metabolism—BCHE—epilepsy syndrome	5.35e-06	8.36e-05	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling Pathways—CASP3—epilepsy syndrome	5.34e-06	8.36e-05	CbGpPWpGaD
Bisoprolol—ADRB2—GPCR downstream signaling—AKT1—epilepsy syndrome	5.27e-06	8.25e-05	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling Pathways—CASP3—epilepsy syndrome	5.22e-06	8.17e-05	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling Pathways—JUN—epilepsy syndrome	5.19e-06	8.12e-05	CbGpPWpGaD
Bisoprolol—CYP3A4—Metabolism—SLC2A1—epilepsy syndrome	5.1e-06	7.98e-05	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling Pathways—JUN—epilepsy syndrome	5.07e-06	7.94e-05	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling Pathways—MMP9—epilepsy syndrome	5.05e-06	7.9e-05	CbGpPWpGaD
Bisoprolol—CYP3A4—Metabolism—PLCB1—epilepsy syndrome	5.04e-06	7.89e-05	CbGpPWpGaD
Bisoprolol—CYP3A4—Metabolism—TH—epilepsy syndrome	5.03e-06	7.86e-05	CbGpPWpGaD
Bisoprolol—CYP2D6—Metabolism—AGT—epilepsy syndrome	5.02e-06	7.86e-05	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling Pathways—MMP9—epilepsy syndrome	4.94e-06	7.72e-05	CbGpPWpGaD
Bisoprolol—CYP2D6—Metabolism—APOE—epilepsy syndrome	4.92e-06	7.7e-05	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling by GPCR—AKT1—epilepsy syndrome	4.89e-06	7.66e-05	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling by GPCR—AKT1—epilepsy syndrome	4.79e-06	7.49e-05	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling Pathways—SRC—epilepsy syndrome	4.65e-06	7.28e-05	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling Pathways—SRC—epilepsy syndrome	4.55e-06	7.12e-05	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling Pathways—VEGFA—epilepsy syndrome	4.53e-06	7.09e-05	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling Pathways—VEGFA—epilepsy syndrome	4.43e-06	6.94e-05	CbGpPWpGaD
Bisoprolol—CYP2D6—Metabolism—POMC—epilepsy syndrome	4.23e-06	6.61e-05	CbGpPWpGaD
Bisoprolol—CYP3A4—Metabolism—HMOX1—epilepsy syndrome	4.19e-06	6.56e-05	CbGpPWpGaD
Bisoprolol—CYP3A4—Metabolism—CAT—epilepsy syndrome	4.14e-06	6.48e-05	CbGpPWpGaD
Bisoprolol—CYP3A4—Metabolism—ABCB1—epilepsy syndrome	4.03e-06	6.3e-05	CbGpPWpGaD
Bisoprolol—CYP2D6—Metabolism—ALB—epilepsy syndrome	3.85e-06	6.03e-05	CbGpPWpGaD
Bisoprolol—CYP3A4—Metabolism—GPX1—epilepsy syndrome	3.74e-06	5.86e-05	CbGpPWpGaD
Bisoprolol—CYP2D6—Metabolism—PTGS2—epilepsy syndrome	3.37e-06	5.27e-05	CbGpPWpGaD
Bisoprolol—CYP3A4—Metabolism—AGT—epilepsy syndrome	3.28e-06	5.14e-05	CbGpPWpGaD
Bisoprolol—CYP3A4—Metabolism—APOE—epilepsy syndrome	3.22e-06	5.03e-05	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling Pathways—AKT1—epilepsy syndrome	2.89e-06	4.52e-05	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling Pathways—AKT1—epilepsy syndrome	2.83e-06	4.43e-05	CbGpPWpGaD
Bisoprolol—CYP3A4—Metabolism—POMC—epilepsy syndrome	2.76e-06	4.32e-05	CbGpPWpGaD
Bisoprolol—CYP3A4—Metabolism—ALB—epilepsy syndrome	2.52e-06	3.94e-05	CbGpPWpGaD
Bisoprolol—CYP3A4—Metabolism—PTGS2—epilepsy syndrome	2.2e-06	3.45e-05	CbGpPWpGaD
Bisoprolol—CYP2D6—Metabolism—AKT1—epilepsy syndrome	1.69e-06	2.65e-05	CbGpPWpGaD
Bisoprolol—CYP3A4—Metabolism—AKT1—epilepsy syndrome	1.11e-06	1.73e-05	CbGpPWpGaD
